| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |